Mebucain Mint

Cetylpyridinium chloride and lidocaine hydrochloride, the active ingredients in Mebucain Mint, are local anesthetic and antiseptic agents presented as a mint‑flavored oral formulation for oromucosal use. They provide temporary relief of oral mucosal pain, sore throat and mouth ulcers in adults and children.

GNH USA supplies Mebucain Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Mebucain Mint, containing cetylpyridinium chloride and lidocaine hydrochloride, is used for symptomatic relief of oral mucosal conditions.

- Sore throat: provides temporary numbing and antiseptic action to ease pain. - Mouth ulcers: reduces discomfort and helps control bacterial growth. - Oral mucosal irritation: alleviates pain associated with minor injuries or inflammation.

Mebucain Mint may cause local adverse reactions, most of which are mild and transient.

Common Side Effects: - Taste alteration: temporary metallic or minty taste. - Mild oral irritation: transient burning or tingling sensation. - Numbness: temporary loss of sensation at the site of application. - Dry mouth: occasional reduced salivation.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe oral ulceration: persistent ulceration beyond expected healing. - Systemic toxicity: rare signs of lidocaine overdose such as dizziness, irregular heartbeat, or seizures.

Before using Mebucain Mint, consider the following precautions. - Age restriction: not recommended for children under 2 years without medical advice. - Allergies: avoid if known hypersensitivity to lidocaine, cetylpyridinium chloride or related compounds. - Pregnancy: consult a healthcare professional before use as safety data are limited. - Concurrent oral medications: do not use simultaneously with other topical anesthetics to avoid additive effects. - Application area: apply only to intact mucosa; avoid excessive use on damaged tissue. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Mebucain Mint can interact with certain medications, mainly through additive local‑anesthetic effects or altered antiseptic activity.

Major Interactions (Avoid): - Other topical anesthetics: combined use may increase risk of systemic lidocaine toxicity. - Anticoagulants (e.g., warfarin): prolonged mucosal exposure may increase bleeding risk if ulceration occurs.

Moderate Interactions (Monitor Closely): - Alcohol‑based oral antiseptics: may enhance local irritation. - CYP3A4 inhibitors: lidocaine metabolism may be reduced, raising systemic levels. - Antihistamines: could mask early signs of an allergic reaction.